Immunofluorescence staining on tumor tissues found that the expression level of CD31, a blood vessel marker, was significantly decreased in tumors from WT mice after the treatment of STING agonist, but not in tumors from Stingfl/fl/Cdh5-Cre mice. This evidence concerns the gene STING1 and neoplasm.